Loss of expression of Syndecan-1 is associated with Tumor Recurrence, Metastatic Potential, and Poor Survival in patients with Colorectal carcinoma

OBJECTIVE: The loss of expression of syndecansyndecan-1 is associated with poor prognosis in many types of human cancer. The objective of this study was to evaluate the relation between syndecan-1 immunoexpression and several clinicopathological parameters in a subset of colorectal carcinoma (CRC) p...

Descripción completa

Detalles Bibliográficos
Autor principal: Al-Maghrabi, Jaudah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794120/
https://www.ncbi.nlm.nih.gov/pubmed/33437261
http://dx.doi.org/10.12669/pjms.37.1.2592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794120/
https://www.ncbi.nlm.nih.gov/pubmed/33437261
http://dx.doi.org/10.12669/pjms.37.1.2592

Ejemplares similares